Envoy Medical, a hearing health company focused on fully implanted hearing systems, has been awarded another patent. This patent – “Implantable Cochlear System with Inner Ear Sensor” (Document ID: US 11806531 B2) – is one of a growing number of patents that Envoy Medical has applied for or secured as part of its implantable hearing devices technology portfolio.
“We are excited to announce this new patent, which gives us an additional opportunity to evolve and grow our designs over time,” says Brent Lucas, Envoy Medical’s DEO. “We’ve made no secret of our intent to disrupt the hearing implant market with our fully implanted Acclaim cochlear implant, but we also have a strategy to maintain that momentum with additional advances in the implantable hearing device market for years to come.”
Further reading: Envoy Medical: Interview with CEO Brent Lucas
Envoy Medical says its fully implanted Acclaim Cochlear Implant is aimed at being a first-of-its-kind fully implanted cochlear implant. Envoy Medical’s fully implanted technology includes a sensor designed to leverage the natural anatomy of the ear instead of a microphone to capture sound.
The Acclaim is designed to address severe to profound sensorineural hearing loss that is not adequately addressed by hearing aids. The Acclaim is expected to be indicated for adults who have been deemed adequate candidates by a qualified physician, according to the company.
The Acclaim Cochlear Implant received the Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) in 2019. We believe the Acclaim was the first hearing-focused device to receive Breakthrough Device Designation.